EICHORPublic-registry site landscape for NCT05265910, “A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis”, a Allergic Conjunctivitis study sponsored by Andover Research Eye Institute. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05265910 (registry record) |
| Study title | A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis |
| Official title | A Single-Center, Randomized, Double-Masked, Parallel Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Reducing Ocular Itching in Subjects With Allergic Conjunctivitis |
| Sponsor | Andover Research Eye Institute |
| Condition(s) | Allergic Conjunctivitis |
| Phase | PHASE4 |
| Listed sites | 1 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT05265910.
Eichor generates a preliminary site-risk snapshot for NCT05265910 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Allergic Conjunctivitis trials
← Eichor home · All tracked trials · Allergic Conjunctivitis studies · Weekly briefs
